Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 14.068.019.448.442.98

What is the latest Core EBITDA Margin ratio of SOTAC PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of SOTAC PHARMACEUTICALS is 14.06 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202514.06
Mar20248.01
Mar20239.44
Mar20228.44
Mar20212.98

How is Core EBITDA Margin of SOTAC PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2025 14.06
75.53
Mar2024 8.01
-15.15
Mar2023 9.44
11.85
Mar2022 8.44
183.22
Mar2021 2.98 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹118.3 Cr 1% -12.2% -31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,323.0 Cr 1.7% -5.7% -7.4% Stock Analytics
DIVIS LABORATORIES ₹160,825.0 Cr 0.8% -6.7% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,349.0 Cr 0.6% 4.3% 24.4% Stock Analytics
CIPLA ₹106,048.0 Cr -4.7% -12.3% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,494.0 Cr 6.3% -2.1% -4.1% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

1%

-12.2%

-31.8%

SENSEX

-1.7%

-4.3%

6.2%


You may also like the below Video Courses